Deborah joined Milford in early 2020 as an Investment Analyst covering Global Equities. Prior to joining Milford, Deborah was an Associate in the Investment Banking Team at Jarden where she worked on a number of Mergers and Acquisitions & Equity Capital Markets (ECM) transactions including the sale of Aegis, the sale of TRG Imaging, the purchase of Hellers, and a number of capital raises.
Prior to this, Deborah worked as a medical Doctor at Capital & Coast District Health Board, and was Chair of the New Zealand Medical Association Doctors in Training Council. Deborah also has an interest in online education and co-founded LearnCoach with David Cameron in 2015, which is widely used by NCEA students.
Deborah holds a Bachelor of Medicine and Bachelor of Surgery, Bachelor of Medical Science (Honours), Master of Entrepreneurship (Distinction) and is a CFA Charterholder.
Thermo Fisher Scientific is a company at the centre of the fight against COVID-19. Global Equities Analyst Dr Deborah Lambie shares the story behind their success and how our investment in the company has helped deliver good returns for investors.
Disclaimer: This is issued by Milford Funds Limited and Milford Australia Pty Ltd ABN 65 169 262 971, AFSL 461253, and is intended to provide general information only. It does not take into account your investment needs, objectives, financial situation or personal circumstances. It is not intended to be viewed as investment or financial advice. Before making any financial decisions, consider whether the information is suitable for your circumstances and whether you wish to seek independent financial advice. Past performance is not a guarantee of future performance.
Previous
Two investor behaviours worth avoiding
Next
Vaccine Time: The Beginning of the Pandemic’s End
